Bioventus (NYSE:BVS – Get Rating) and Modular Medical (OTC:MODD – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership. Volatility & Risk Bioventus has a beta of 0.48, meaning […]
The Law Offices of Frank R. Cruz announces an investigation of Bioventus Inc. on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a. | November 28, 2022
Bioventus (NYSE:BVS – Get Rating) issued its earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.01), MarketWatch Earnings reports. Bioventus had a return on equity of 21.93% and a net margin of 2.67%. During the same period in the prior year, […]